Genprex, Inc. (GNPX)
1.90
-0.08
(-4.04%)
USD |
NASDAQ |
Oct 23, 10:27
Genprex Market Cap : 0.9618M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 1.002M |
| October 21, 2026 | 1.038M |
| October 20, 2026 | 1.078M |
| October 19, 2026 | 1.043M |
| October 16, 2026 | 1.068M |
| October 15, 2026 | 1.159M |
| October 14, 2026 | 1.179M |
| October 13, 2026 | 1.271M |
| October 12, 2026 | 1.362M |
| October 09, 2026 | 1.377M |
| October 08, 2026 | 1.392M |
| October 07, 2026 | 1.326M |
| October 06, 2026 | 1.321M |
| October 05, 2026 | 1.377M |
| October 02, 2026 | 1.331M |
| October 01, 2026 | 1.296M |
| September 30, 2026 | 1.478M |
| September 29, 2026 | 1.443M |
| September 28, 2026 | 1.422M |
| September 25, 2026 | 1.665M |
| September 24, 2026 | 1.782M |
| September 23, 2026 | 1.898M |
| September 22, 2026 | 1.792M |
| September 21, 2026 | 1.762M |
| September 18, 2026 | 1.746M |
| Date | Value |
|---|---|
| September 17, 2026 | 1.752M |
| September 16, 2026 | 1.726M |
| September 15, 2026 | 1.676M |
| September 14, 2026 | 1.746M |
| September 11, 2026 | 1.696M |
| September 10, 2026 | 1.696M |
| September 09, 2026 | 1.736M |
| September 08, 2026 | 1.792M |
| September 04, 2026 | 1.772M |
| September 03, 2026 | 1.734M |
| September 02, 2026 | 1.777M |
| September 01, 2026 | 1.797M |
| August 31, 2026 | 1.878M |
| August 28, 2026 | 1.858M |
| August 27, 2026 | 1.827M |
| August 26, 2026 | 2.010M |
| August 25, 2026 | 2.025M |
| August 24, 2026 | 2.035M |
| August 21, 2026 | 2.000M |
| August 20, 2026 | 2.000M |
| August 19, 2026 | 2.020M |
| August 18, 2026 | 2.000M |
| August 17, 2026 | 2.265M |
| August 14, 2026 | 2.187M |
| August 13, 2026 | 2.465M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.403B |
| Alnylam Pharmaceuticals, Inc. | 29.98B |
| Anika Therapeutics, Inc. | 282.25M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.178B |
Market Cap Related Metrics
| Price to Book Value | 0.0650 |
| Price | 1.90 |
| Earnings Yield | -8.36K% |